Increased levels of α V-associated integrins in association with growth inhibition of cultured tumor cells by bromodeoxyuridine

Anticancer Research

Volumn 17, Issue 2 A, 1997, Pages 833-838

  Yoshihara, Takao ^a,b   Hibi, Shigeyoshi ^a   Tsunamoto, Kentaro ^a   Todo, Shinjiro ^a   Imashuku, Shinsaku ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Fukui Prefectural University   (Japan)

Author keywords

Bromodeoxyuridine; Ewing's sarcoma; Integrins; Neuroblastoma; Peripheral neuroepithelioma

Indexed keywords

AGAR; BROXURIDINE; INTEGRIN; VITRONECTIN;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL ADHESION; CELL STRUCTURE; CONTROLLED STUDY; CULTURE MEDIUM; EWING SARCOMA; HUMAN; HUMAN CELL; NEUROBLASTOMA; NEUROEPITHELIOMA; PRIORITY JOURNAL;

ANDROGENS; ANTIMETABOLITES, ANTINEOPLASTIC; BROMODEOXYURIDINE; CELL ADHESION; CELL DIVISION; HUMANS; INTEGRINS; NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030945354     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Hynes RO: Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69: 11-25, 1992.
2. Ruoslahti E: Control of cell motility and tumor invasion by extracellular matrix interactions. Br J Cancer 66: 239-242, 1992.
3. Brooks PC, Montgomery AMP, Rosenfeld M, Reisfeld RA, Hu T, Klier G and Cheresh DA: Integrin α V β 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79: 1157-1164, 1994.
4. Felding-Haberman B, Mueller BM, Romerdahl CA and Cheresh DA: Involvement of integrin α V gene expression in human melanoma tumorigenicity. J Clin Invest 89: 2018-2022, 1992.
5. Albelda SM, Mette SA, Elder DE, Stewart RM, Damjanovich L, Herlyn M, and Buch CA: Integrin distribution in malignant melanoma: association of the β 3 subunit with tumor progression. Cancer Res 50: 6757-6764, 1990.
6. Seftor REB, Seftor EA, Gehlsen KR, Stetler-Stevenson WG, Brown PD, Ruoslahti E and Hendrix MJC: Role of the α V α 3 integrin in human melanoma cell invasion. Proc Natl Acad Sci USA 89: 1557- 1561, 1992.
7. Montgomery AMP, Reisfeld RA and Cheresh DA: Integrin α V β 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc Natl Acad Sci USA 91: 8856-8860, 1994.
8. Giancotti FG and Ruoslahti E: Elevated levels of the α 5 β l fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell 60: 849-859, 1990.
9. Schreiner C, Fisher M, Hussein S and Jiliano RL: Increased tumorigenicity of fibronectin receptor deficit Chinese hamster ovary cell variants. Cancer Res 51: 1738-1740, 1991.
10. Yoshihara T, Ikushima S, Shimizu Y, Esumi N, Todo S, Humphries MJ and Imashuku S: Distinct mechanism of human neuroblastoma cell adhesion to fibronectin. Clin Exp Metastasis 9: 363-375, 1991.
11. Rossino P, Defilippi P, Silengo L and Tarone G: Up-regulation of the integrin α 1 / β l in human neuroblastoma cells differentiated by retinoic acid: correlation with increased neurite outgrowth response to iaminin. Cell Regulation 2: 1021-1033, 1991.
12. Yoshihara T, Esumi N, Humphries MJ and Imashuku S: Unique expression of integrin fibronectin receptors in human neuroblastoma cell lines. Int J Cancer 51: 620-626, 1992.
13. Tsunamoto K, Todo S, Imashuku S and Kato K: Induction of S100 protein by 5-bromo-2'-deoxyuridine in human neuroblastoma cell lines. Cancer Res 48: 170-174, 1988.
14. Israel MA, Thiele C, Whang-Peng J, Kao-Shan S-S, Triche TJ and Miser J: Peripheral neuroepithelioma: genetic analysis of tumor derived cell lines. In: Advance in Neuroblastoma Research, (Evans AV, D'Angio GJ and Seeger RC, eds). New York, Alan R Liss Inc, 1985, pp 161-170.
15. Cavazzana AO, Miser JS, Jefferson J and Triche TJ: Experimental evidence for a neural origin of Ewing's sarcoma of bone. Am J Pathol 127: 507-518, 1987.
16. Sekiguchi M, Ota T, Sakakibara K, Inui N and Fujii G: Establishment and characterization of a human neuroblastoma cell line in tissue culture. Jpn J Exp Med 49: 67-83, 1979.
17. Yoshihara T, Inaba T, Shapiro LH, Kato J and Look AT: E2A-HLFmediated cell transformation requires both the frans-activation domains of E2A and the leucine zipper dimerization domain of HLF. Mol Cell Biol 15: 3247-3255, 1995.
18. Cheresh DA and Harper JR: Arg-Gly-Asp recognition by a cell adhesion receptor requires its 130 kDa α-subunit. J Biol Chem 262: 1434-1437, 1987.
19. Hemler ME, Huang C and Schwarz L: The VLA protein family. J Biol Chem 262: 3300-3309, 1987.
20. Pischel KD, Hemler ME, Huang C, Bluestein HG and Woods VL: Use of the monoclonal antibody 12F1 to characterize the differentiation antigen VLA-2. J Immunol 138: 226-233, 1987.
21. Sonnenberg A, Modderman PW, and Hogervorst F: Laminin receptor on platelets is the integrin VLA-6. Nature 336: 487-489, 1988.
22. Newman PJ, Allen RW, Kahn RA and Kunicki TJ: Quantitation of membrane glycoprotein Ilia on intact human platelets using the monoclonal antibody, AP-3. Blood 65: 227-232, 1985.
23. Plantefaber LC and Hynes RO: Changes in integrin receptors on oncogenically transformed cells. Cell 56: 281-290, 1989.